Olr956 inhibitors represent a distinctive class of chemical compounds characterized by their ability to modulate the activity of the olr956 gene product, which encodes a specific protein involved in cellular processes. This gene, which is part of the larger olfactory receptor gene family, plays a significant role in the molecular signaling pathways that influence various physiological functions. The inhibitors specifically target and interact with the olr956 protein, which can affect its normal functioning. The structure of these inhibitors typically includes various functional groups that facilitate binding to the active site of the olr956 protein or modulate its conformational state, thereby altering its activity.
The chemical properties of olr956 inhibitors are diverse, often including heterocyclic rings, aromatic systems, and various substituents that enhance their binding affinity and specificity. The design of these inhibitors is guided by a detailed understanding of the olr956 protein's three-dimensional structure and the molecular interactions at play. Through techniques such as crystallography and molecular modeling, researchers can identify key binding sites and optimize the chemical structures of these inhibitors for better performance. The activity of olr956 inhibitors can be influenced by factors such as the presence of functional groups that can form hydrogen bonds, hydrophobic interactions, or electrostatic interactions with the target protein. Understanding these interactions is crucial for elucidating the precise mechanisms by which these inhibitors affect the olr956 protein and its associated pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $128.00 $638.00 | 7 | |
mTOR inhibitor, could affect cell growth and proliferation pathways, potentially influencing Olr956 activity. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
Dual EGFR and HER2 inhibitor, might modulate signaling pathways relevant to Olr956's function. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Multi-targeted receptor tyrosine kinase inhibitor, potentially disrupting several signaling pathways involving Olr956. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Inhibits multiple kinases, could affect pathways influencing Olr956, like angiogenesis or cell proliferation. | ||||||
Vandetanib | 443913-73-3 | sc-220364 sc-220364A | 5 mg 50 mg | $167.00 $1353.00 | ||
Inhibits VEGFR, EGFR, and RET tyrosine kinases, potentially altering signaling pathways relevant to Olr956. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $127.00 $178.00 | 2 | |
Inhibits multiple tyrosine kinases, might modulate pathways involved in angiogenesis and growth, affecting Olr956. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $74.00 $119.00 | 33 | |
EGFR tyrosine kinase inhibitor, could disrupt signaling pathways that influence Olr956 activity. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
EGFR inhibitor, potentially altering pathways that Olr956 is involved in, especially in cell proliferation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Src family kinase inhibitor, might alter cell proliferation and survival pathways affecting Olr956. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
BCR-ABL kinase inhibitor, potentially affecting cell proliferation and survival pathways influencing Olr956. | ||||||